SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
McROBBIE-JOHNSON ANDREAS A

(Last) (First) (Middle)
605 W. KNOX RD., SUITE 202

(Street)
TEMPE AZ 85284

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
eWELLNESS HEALTHCARE Corp [ NA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) X Other (specify below)
Former President/CEO/Director
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 per share 05/06/2014 J(1) 5,000,000 D (1) 5,000,000 D
Common Stock, par value $0.001 per share 05/06/2014 S(2) 4,600,000 D (2) 400,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Pursuant to the terms and conditions of that certain Amended and Restated Share Exchange Agreement, dated as of April 30, 2014 ("Share Exchange Agreement"), among eWellness Healthcare Corporation (f/k/a Dignyte, Inc.), a Nevada corporation ("eWellness Healthcare"), Andreas A. McRobbie-Johnson (the "Reporting Person"), eWellness Corporation, a Nevada corporation ("eWellness"), and the holders of all of the issued and outstanding stock of eWellness (the "Shareholders"), the Reporting Person cancelled 5,000,000 shares of his eWellness Healthcare common stock which decreased the number of eWellness Healthcare common stock beneficially owned by the Reporting Person from 10,000,000 to 5,000,000 ("Cancellation of Shares"). The Reporting Person did not receive any cash consideration for the cancellation of his shares of eWellness Healthcare common stock.
2. Pursuant to the terms and conditions of the Share Exchange Agreement, the Reporting Person transferred 3,100,000 shares of his eWellness Healthcare common stock to parties designated by eWellness and 1,500,000 shares of his eWellness Healthcare common stock to Summit Capital USA, Inc., which decreased the number of eWellness Healthcare common stock beneficially owned by the Reporting Person from 5,000,000 to 400,000, representing 2.63% of the issued and outstanding common stock of eWellness Healthcare (collectively, the "Transfer of Shares"). The foregoing percentage is calculated based on 15,200,000 shares of eWellness Healthcare common stock issued and outstanding as of May 6, 2014, as disclosed in a Form 8-K filed by the eWellness Healthcare with the Securities and Exchange Commission on May 6, 2014. The Reporting Person did not receive any cash consideration for the Transfer of Shares.
Remarks:
Pursuant to the terms and conditions of the Share Exchange Agreement, on May 6, 2014 (the effective date of closing of the transactions under the Share Exchange Agreement), the Reporting Person resigned from all of his positions with eWellness Healthcare, including, but not limited to, chief executive officer, president and director. In addition, after the Cancellation of Shares and the Transfer of Shares as reported herein, the Reporting Person no longer beneficially owns more than 10% of the issued and outstanding common stock of eWellness Healthcare. Accordingly, the Reporting Person is no longer a reporting person subject to the requirements of Section 16 of the Securities Exchange Act of 1934.
/s/ Andreas A. McRobbie-Johnson 01/22/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.